Trial record 6 of 6 for:    Open Studies | "Carbon Monoxide Poisoning"

End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning

This study is currently recruiting participants. (see Contacts and Locations)
Verified July 2014 by Minneapolis Medical Research Foundation
Sponsor:
Information provided by (Responsible Party):
Minneapolis Medical Research Foundation
ClinicalTrials.gov Identifier:
NCT01859156
First received: May 8, 2013
Last updated: July 31, 2014
Last verified: July 2014
  Purpose

The purpose of this study is to determine whether a relationship exists between EtCO2 and carboxyhemoglobin levels in carbon monoxide exposure. Our hypothesis is that a liner relationship exists between EtCO2 and carboxyhemoglobin in carbon monoxide poisoning.


Condition
Carbon Monoxide Exposure

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide

Resource links provided by NLM:


Further study details as provided by Minneapolis Medical Research Foundation:

Primary Outcome Measures:
  • EtCO2 [ Time Frame: Immediately upon study enrollment, an average time of 30 minutes post arrival to the hospital. ] [ Designated as safety issue: No ]
    The EtCO2 level is measured by capnography and compared to the carboxyhemoglobin level.


Estimated Enrollment: 150
Study Start Date: October 2006
Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts
Carbon Monoxide Exposure

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients presenting to the emergency department at an urban county hospital.

Criteria

Inclusion Criteria:

  • Carbon monoxide exposure

Exclusion Criteria:

  • Less than 18 years old
  • Suicide attempt
  • Unable to provide informed consent
  • Pregnant
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01859156

Contacts
Contact: James R Miner, MD 612-873-8791 research.hcmed@gmail.com

Locations
United States, Minnesota
Hennepin County Medical Center Recruiting
Minneapolis, Minnesota, United States, 55415
Contact: James R Miner, MD    612-873-8791    research.hcmed@gmail.com   
Principal Investigator: James R Miner, MD         
Sponsors and Collaborators
Minneapolis Medical Research Foundation
Investigators
Principal Investigator: James R Miner, MD Minneapolis Medical Research Foundation
  More Information

No publications provided

Responsible Party: Minneapolis Medical Research Foundation
ClinicalTrials.gov Identifier: NCT01859156     History of Changes
Other Study ID Numbers: 06-2713
Study First Received: May 8, 2013
Last Updated: July 31, 2014
Health Authority: United States: Institutional Review Board

Keywords provided by Minneapolis Medical Research Foundation:
Carbon Monoxide
Carboxyhemoglobin
End-tidal carbon dioxide
Capnography

Additional relevant MeSH terms:
Carbon Monoxide Poisoning
Gas Poisoning
Poisoning
Chemically-Induced Disorders
Carbon Monoxide
Antimetabolites
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Gasotransmitters
Neurotransmitter Agents
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on August 28, 2014